Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

Roche shares slip as profits miss expectations

Roche shares slip as profits miss expectations and Perjeta (pertuzumab) - which collectively grew 19% to CHF 8.76bn.

Roche's Kadcyla fails in gastric cancer trial

Roche's Kadcyla fails in gastric cancer trial Among its best-performing products were breast cancer therapy Perjeta (pertuzumab), up 66% to CHF 1.04bn in the nine-month period, and this in turn helped boost sales of Herceptin

Roche's Perjeta launches in UK for early breast cancer

Roche's Perjeta launches in UK for early breast cancer Roche's Perjeta is now licensed for use in the UK as a treatment for early-stage breast cancer, a few weeks after the new indication was approved in Europe. ... Perjeta was already approved to treat previously-untreated advanced HER2-positive breast

European approval for Roche’s next-gen breast cancer drug

European approval for Roche’s next-gen breast cancer drug Perjeta now available in EU for use before surgery in early stage aggressive breast cancer.  . ... We are committed to making the Perjeta regimen available to appropriate patients in the EU as early as possible.”.

UK pharma rebate payment doubles in one year

UK pharma rebate payment doubles in one year First quarter repayment £138m higher than this time last year

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Using video to enhance clinical trial patient recruitment and retention
With the clinical study landscape more competitive than ever, advertising and marketing have never been more important. They can mean the difference between successful patient recruitment and study failure. In...
DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....

Infographics